A central component of malaria control initiatives throughout the world is the use of artemisinin-based combination therapies (ACTs) for treatment of uncomplicated P. falciparium malaria. Despite the well-documented clinical efficacy of ACTs, the population-level effects of ACT case management on malaria transmission have not been studied thoroughly until recently. An ideal case study for the population-level effects of artemisinin use can be found in Vietnam, where a major increase of malaria cases in the 1980s was followed by the gradual adoption of artemisinin-based clinical case management.
Introduction
. Incidence of suspected, confirmed, and estimated cases of malaria per 1,000 person-years by region from 1991-2014 on a log-transformed scale where labels correspond to raw (unlogged) values. In 2014, there were 473 confirmed cases in the northern region, 12,006 confirmed cases in the central region, and 2,462 cases in the southern region. strengthening were recorded in annual reports produced by Vietnam's National Institutes for 32 Malariology, Parasitology, and Entomology (NIMPE). An analysis of these data for the provinces in the 33 southern part of the country from 1991-2010 showed that the strongest association with reduced malaria 34 incidence was the proportion of stocked or ordered antimalarial drugs that were artemisinin derivatives 35 [27] . In the present study, we co-analyze these data with national reports collected for Vietnam's central 36 and northern provinces, extending the analysis through 2014. We make several new observations about 37 the factors that are most closely associated with reduced malaria incidence and about the regional 38 variation in associations in the northern, central, and southern parts of the country. We also consider 39 the case reporting process and diagnostic capabilities of Vietnam's national malaria program in order to 40 improve our estimates of the malaria case burden in Vietnam over the past two and a half decades. Our 41 findings underscore the robustness of the association between adoption of artemisinin-containing 42 antimalarials for case management of P. falciparum and malaria decline, and we hope they will inform 43 the development of effective public health strategies for eliminating malaria in Vietnam in the near 44 future.
Figure 2. Incidence of suspected, confirmed, and estimated cases of malaria, by province . Provinces are arranged approximately by decreasing latitude (north to south) from top to bottom, and left to right. The y-axis is log-transformed, but the labels correspond to raw (unlogged) values and the"0.0" label on the y-axis corresponds to true zero. provinces, and 0.0001 < p < 0.001 in 6 provinces). The remaining provinces did not have strong support 92 for either an upward or downward trend in vector control. The capacity of the health system, as 93 measured by staff trainings per 100 persons was not strongly associated with time in the majority of 94 provinces. The discretionary budget per capita decreased significantly over time in 24 provinces (p < 95 0.0001 in 17 provinces, and 0.0001 < p < 0.001 in 7 provinces ), indicating that a budget increase was 96 likely not a contributing factor to the decline of malaria in these provinces. However, it is important to 97 remember that budgets and staff were reduced in many provinces because of the success of the control 98 program; hence, this is a covariate whose estimates are difficult to interpret. No other trends were 99 strongly supported in the remaining 27 provinces.
100
Regression Results. In the nationwide analysis using all 51 provinces, after controlling for the 101 proportion of the population living in urban areas and for the proportion of the population protected by 102
ITNs or IRS, the proportion of treatments for P. falciparum that contained artemisinin was significantly 103 (p < 0.001) and inversely associated with all three measures of malaria incidence (Figure 4) . A 10% 104 increase in the proportion of treatments containing artemisinin was found to be associated with a 32.8% 105 (95% CI: 27.7 -37.5%) reduction in the incidence of estimated cases. The proportion of the population 106 living in urban areas was found to be significantly inversely associated with the number of suspected 107 malaria cases (p < 0.001) and the number of estimated cases (p < 0.05), but not with the number of 108 confirmed malaria cases (p = 0.48). The proportion of the population protected by vector control , by region and nationwide, as predicted by models using these three covariates only. The circle shows the mean effect size, the solid line shows the 95% confidence interval, and the dotted lines shows the 99.9% confidence interval. Outcome variable used in model is indicated by color. For clarity, the x-axis has been limited to range from -90% to 90%.
measures was not found to be significantly associated with any of the three measures of malaria 110 incidence in the nationwide analysis.
111
When we additionally controlled for changes in health system capacity using the number of staff 112 trainings per capita and the discretionary budget per capita, we similarly found that the proportion of 113 treatments for P. falciparum containing artemisinin was significantly (p < 0.001) inversely associated 114 with malaria incidence, as measured by suspected, confirmed, and estimated cases ( Figure 5 ). Again, no 115 significant associations were found between the proportion of the population protected by vector control 116 and any of the three measures of malaria incidence. The proportion of the population living in urban 117 areas was significantly inversely associated with the incidence of suspected cases (p = 0.004), but no 118 associations were found between urbanization and estimated cases (p = 0.15) or confirmed cases 119 (p = 0.29). The discretionary budget per capita was found to be positively but weakly associated with 120 the number of suspected cases, with a 10% budget increase corresponding to a 1.35% (95% CI: 0.09 -121 2.6%) increase in the number of suspected cases (p = 0.035). The number of staff trainings was not 122 found to be significantly associated with any incidence measure. Figure 4 , with the addition of covariates measuring health system capacity.
Regional Variation in Regression Results. We found the proportion of purchased P. incidence can be seen for the central provinces, although it is only significant when looking at suspected 129 malaria cases, suggesting that urbanization may have generally decreased incidence of non-specific rural 130 febrile diseases (including malaria). The relationship between urbanization and malaria in the northern 131
provinces is difficult to assess as the inferred associations were not robust across models and covariates. 132
There was no evidence of a relationship between urbanization and malaria in the southern provinces.
133
Although the proportion of the population protected by vector control measures was not found to be 134 significantly associated with malaria incidence when all provinces where analyzed together, a few 135 significant associations were identified when the analysis was stratified by region. In the three-covariate 136 models, the proportion protected by vector control measures was significantly inversely associated with 137 all three measures of malaria incidence (p < 0.01) in the northern provinces. However, in the 138 five-covariate models, this association only remained significant for incidence measured by suspected 139 10/29 cases and the directionality of the effect was reversed.
140
In the three-covariate models for the central provinces, the proportion of the population protected by 141 vector control measures was significantly positively associated with the number of suspected cases 142 (p < 0.001) and with the number of estimated cases (p < 0.05). In the five-covariate models for the 143 central provinces, the proportion of the population protected by vector control measures remained 144 significantly positively associated with the number of suspected cases (p < 0.01), but was no longer 145 significantly associated with the number of estimated cases. Neither the three-covariate model nor the 146 five-covariate model revealed any significant associations between the population protected by vector 147 control and any measure of incidence in the southern provinces. The lack of robustness in these results 148 and the presence of positive associations between vector control and malaria led us to believe that the 149 NIMPE/IMPE data did not contain any evidence for an effect of vector control on reducing malaria 150 incidence.
151
The discretionary budget was not significantly associated with any of the three measures of incidence 152 in any of the three regions (but see Appendix Figure S2a for results using alternative dose-to-course 153 conversions). Staff trainings were significantly negatively associated with confirmed and estimated 154 (p < 0.05) cases in the central region; however, in the northern region, staff trainings were significantly 155 positively associated with confirmed (p < 0.01) and estimated (p < 0.001) cases. Overall, the health 156 capacity variables do not have robust associations with malaria incidence; again, it is important to 157 remember that as malaria incidence drops, budgets and staff numbers for malaria control programs will 158 also be reduced. practice these effects can be non-linear and an increase from 0% to 20% may not have the same effect as 188 an increase from 20% to 40%. Likewise, in Vietnam, increasing access to ITNs may have reduced 189 incidence even more quickly, but there were no provinces in the data set that showed a rapid scale-up of 190 ITS/IRS coverage. This finding is consistent with descriptions of the control program as it was being 191 implemented in the 1990s [28] . 192 It is also possible that in low transmission areas, ACT case management is more effective than ITN 193 use as a general malaria control policy, whereas the reverse may be true for high transmission areas.
194
ACT case management is a control strategy that works by targeting symptomatic and infected 195 individuals, while vector control acts broadly to protect the entire at-risk population. In addition, ACT 196 case management may be less effective at reducing transmission in highly endemic areas due to the 197 presence of asymptomatic cases that may never be diagnosed and treated [31, 32] . In Vietnam, where diagnosis, and the existence of a centralized malaria health system, it is likely that over-reporting of 222 suspected malaria cases is occurring in the northern provinces. It is much less likely that a lack of 223 microscopes, microscopists, or a truly low positive predictive value of clinical diagnosis is the cause of 224 the large number of suspected cases reported from the north. Our estimate of malaria incidence is based 225 on (1) the assumption that the true number of cases is greater than the number of confirmed cases and 226 smaller than the number of suspected cases, and (2) This is an appropriate way of approximating true malaria incidence in provinces where the suspected 228 and confirmed numbers are close, but it works very poorly in provinces (e.g., many in northern Vietnam) 229
where these two numbers differ substantially.
230
One general limitation of using suspected malaria cases from national malaria reports is that this 231 quantity will not include true positives that did not report to the health system due to low severity or 232 lack of symptoms. Individuals with mild symptoms (sub-clinical infections) are less likely to seek care 233 13/29 and, when they do, are more likely to receive a false negative clinical diagnosis. In Vietnam, the path to low malaria incidence has clearly been led by high levels of artemisinin and 255 ACT use in the public sector at coverage rates that can realistically be considered as having a noticeable 256 impact on malaria elimination in some provinces. Active surveillance, reactive case detection, patient 257 compliance, and case follow-up are likely to be key ingredients in Vietnam's next phase of moving the 258 majority of its provinces to zero malaria over the next decade. The major gloom on the horizon is the 259 spread of artemisinin-resistance genotypes in Vietnam [46, 47] , as the arrival of drug-resistance can 260 undermine elimination efforts [48, 49] . It is uncertain if a public health response in this context (e.g., 
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Data Collection. The data used in this analysis were obtained from the Institutes for Malariology, Parasitology, and Entomology (IMPE) located in Ho Chi Minh City and the National Institutes for P. vivax malaria. However, for the y − x cases that remained unconfirmed, the reports do not indicate whether these cases tested negative by microscopy or if they were simply untested. The distinction between cases that tested negative and untested cases could be made if either the positive predictive value, q, of clinical diagnosis or the fraction of clinically suspected cases that undergo blood-slide diagnosis, f BSD , were known. If f BSD is known, then the total number of suspected cases that undergo microscopy, y · f BSD , can be used to calculate the positive predictive value, q, where q has a maximum value of one:
Likewise, if the positive predictive value is known, then the fraction of suspected cases that underwent blood-slide confirmation can be calculated, unless q = 1, in which case all clinically suspected malaria cases are truly malaria. If the rate of blood-slide confirmation, f BSD , is known, then the true number of malaria cases (falciparium and vivax ) can be estimated as:
which is equal to x f BSD when q ≤ 1. Since independent estimates of q or f BSD cannot be obtained, we positive predictive value, as it is likely that clinicians' ability to correctly diagnose a malaria case did not 296 change significantly during this time. This assumption is supported by the opinions of IMPE/NIMPE 297 staff. However, the relative prevalence of other febrile diseases is likely to affect the positive predictive 298 value of malaria clinical diagnosis, depending on the level of similarity between the symptoms of these 299 diseases and malaria symptoms. Unfortunately, incidence data for other febrile diseases are not available. 300
Predictor Data. We identified and collected provincial-level data on potential predictors of 301 provincial malaria case counts in Vietnam from 1991-2014. We used data on vector control measures 302 contained in the annual reports to calculate the proportion of the population protected by vector control 303 measures, as has been done in previous work [27] . These data include the total number of people 304 protected by insecticide-treated bed nets (ITNs) and indoor residual spraying (IRS), reported as the 305 sum of these two measures. ITN coverage is defined by NIMPE as the fraction of households possessing 306 an ITN that was shared by no more than three other individuals [51] . Imputation by linear interpolation 307 16/29 was used to impute missing data on vector control measures.
We also looked at provincial-level data on the proportion of drug purchases for P. falciparum malaria 309 that contained artemisinin. Data on the use of antimalarial drugs were contained in these reports in the 310 form of requests placed by provincial malaria control programs to NIMPE for antimalarial drugs based 311 on projected need for the subsequent year. Requests for antimalarial drugs likely capture true 312 antimalarial drug usage in the country because all public hospitals and health centers in Vietnam 313 provide antimalarial drugs free of charge to individuals suspected of having malaria [27, 50] . We looked 314 at treatments for P. falciparium malaria only because the vast majority of suspected malaria cases were 315 not confirmed by blood-smear for the first half of the time series, and unconfirmed cases were typically 316 presumed to be falciparium and treated as such. Thus, in the analysis, we investigated the association 317 between malaria incidence (falciparium and vivax combined) and the degree to which artemisinin-based 318 drugs were the dominant purchases by local malaria control programs. In a setting where all suspected 319 malaria is confirmed as P. falciparium or P. vivax, artemisinin would only act to reduce falciparum 320 transmission; however, when the majority of cases are unconfirmed, the presumption of falciparum and 321 treatment with artemisinins will act to reduce onward transmission of both falciparum and vivax.
322
Drug purchase data were available for all but three years across the study period (1991, 1993, and 323 1996) and were specified in terms of the drug type and number of units requested (e.g., tablets, pills, 324 tubes). Appendix Table S1 shows the antimalarial drugs ordered by province according to the reports. 325
Since a complete course of treatment for an individual patient usually requires multiple drug units 326 (doses), the number of drug units ordered was converted to the number of courses of treatment for P.
327
falciparum malaria ordered using dose-to-course conversions. These conversions were taken from the 328 national treatment guidelines contained in the annual reports and obtained from conversations with 329 IMPE staff (See Appendix Table S2 ). For drugs that were used to treat more than one type of parasite, 330 the number of courses of treatment for P. falciparum was calculated by dividing the number of drug year-specific relative proportions of P. falciparum cases and P. vivax cases across all provinces as weights. 335
In order to calculate the proportion of treatment courses that contained artemisinin, the number of 336 treatment courses for P. falciparum was then summed for the drugs that contained artemisinin and 337 divided by the number of treatment courses for P. falciparum summed across all drug types. As there 338 was uncertainty about whether primaquine was always used in conjunction with an ACT or whether it 339 17/29 was sometimes used alone, an alternative dose-to-course conversion was considered (see Appendix Figure 340 S2). Where possible, simple linear averaging was used to impute missing data on antimalarial drug 341 requests. For the year 1991, antimalarial drug requests were imputed by linearly extending the 1992 and 342 1993 trend back to 1991 and verifying that the imputed value was less than the values in 1992 and 1993. 343 The reports also contained data on two measures of health system capacity: the discretionary budget 344 and the training of health care workers. Budgetary data, broken down into sub-budget allocations for 345 the local malaria control program, and data on staff trained to support the malaria control program, 346 were both available in the reports by province and year. We used the discretionary budget per capita, 347 which excludes the allocated budget for purchasing antimalarial drugs, insecticides, and subsidies for 348 ITNs and IRS, as a measure of health system capacity after adjusting for historic inflation in the VND. 349 We also used the number of staff trained per capita as a measure of health system capacity. clinically-diagnosed malaria cases (i.e., 'suspected' cases), 2) blood-smear confirmed cases (i.e.,
360
'confirmed' cases), and 3) the estimated true number of malaria cases (i.e., 'estimated' cases) which we 361 obtained by minimizing the year-to-year variation in the positive predictive value of clinical diagnosis, as 362 described above. All case measures include cases of both falciparium and vivax malaria. Five variables, 363 measured by province and by year, were identified as potential predictors of incidence: 1) the proportion 364 of treatment courses for P. falciparum containing artemisinin, 2) the proportion of the population 365 protected by vector control measures, 3) the proportion of the population living in urban areas, 4) the 366 discretionary budget per capita for the malaria control program, and 5) staff trained per 100 persons.
367
Our models included a province-specific fixed effect and the log of the population as an offset term. We 368 used Generalized Estimating Equations (GEE), appropriate for correlated time-series data, to fit our 369 models, and specified a log-link function, an independent correlation structure, and a robust covariance 370 matrix estimator [53] . We also used non-parametric Spearman's rank correlation tests to investigate 371 18/29 temporal trends in potential predictors of case counts.
372
We first fit the models to data from all 51 provinces in Vietnam for the 24 years from 1991-2014.
373
Then, we stratified our province-level data into northern, central, and southern regions and separately fit 374 the models in order to explore whether the relationship between malaria incidence and malaria control 375 measures varied regionally. Regional groupings of provinces are shown in Appendix Figure S1 .
376
Due to missingness in the health system capacity variables, we fit two types of models: models using 377 all five covariates as predictors (i.e., 'five-covariate models') and models using only three covariates (i.e., 378 'three-covariate models' excluding the two measures of health system capacity -discretionary budget per 379 capita and staff trained per 100 persons. The three-covariate models included data from 1991-2014, 380 whereas the five-covariate models included data from 1997-2014. All analysis was conducted in R, using 381 the geepack package for fitting generalized estimating equations [54] . Shape files for creating maps of 382 Vietnam were obtained from the GADM database of Global Administrative Areas.
383 Figure S1 . Northern (orange), central (blue), and southern (red) regional grouping of provinces used in the analysis.
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Table S1
Anti-malarial drugs ordered by province, 1991-2014 (a) Three-covariate models.
(b) Five-covariate models. Figure S2 . Regression results using the alternative calculation for the proportion of treatments containing artemisinin, shown as the percent change in incidence associated with a 10% increase in the listed covariate, by region and for all provinces in Vietnam for a) the models including three covariates only, and for b) the models that included two additional covariates as measures of health system capacity. The circle shows the mean effect size, the solid line shows the 95% confidence interval, and the dotted lines shows the 99.9% confidence interval. Model outcome (estimated, suspected, or confirmed cases) is indicated by effect size color. For clarity, the x-axis has been limited to range from -90 to 90.
